Improving medication adherence in children with leukemia through parenting skills
Official title: Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
Run by Roswell Park Cancer Institute · NCT06074666 · Data updated 2026-11-12
This study is testing a new program to help parents of young children with leukemia make sure their kids take their medicine regularly.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 3 Years to 9 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Roswell Park Cancer Institute Academic / other |
| Locations | 1 site (Buffalo, New York) |
| Status | Recruiting |
| Started | November 7, 2024 |
| Main results expected | October 1, 2027 |
| Study ends | October 1, 2027 |
| Registry record updated | April 23, 2026 |
| Trial ID | NCT06074666 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are parents of children aged 3-9 years who are diagnosed with acute lymphoblastic leukemia and are responsible for their child's medication.
✕Probably not a fit
Patients whose children are not diagnosed with acute lymphoblastic leukemia or are not on home-based oral anti-cancer medication may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot randomized controlled trial evaluates the CareMeds intervention aimed at enhancing medication adherence among young children (ages 3-9) diagnosed with acute lymphoblastic leukemia (ALL). The study will involve 100 families across multiple sites in Buffalo, NY, and Atlanta, GA, comparing the CareMeds program to usual care. The primary focus is to assess the feasibility of the intervention and gather preliminary efficacy data on behavioral parenting skills and medication adherence. Parents will be actively involved, as they hold primary responsibility for their child's medication management.
Why it matters
Potential benefit: If successful, this intervention could significantly improve medication adherence in pediatric patients with leukemia, leading to better health outcomes.
How similar studies have gone: Other studies have shown promise in improving medication adherence through behavioral interventions, suggesting that this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Parent of a child who is diagnosed and being treated for any type of acute lymphoblastic leukemia (ALL) at a study site. * Parent has primary medication responsibility. * Pediatric patient aged 3-9 years * Child on therapy that includes home-based oral anti-cancer medication, such as 6-MP. * Parent has verbal English or Spanish fluency. * Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure Exclusion Criteria: * Parent is unwilling or unable to follow protocol requirements
Where it's running
-
Roswell Park Comprehensive Cancer Center
Buffalo, New York, United States Recruiting
Study contacts
- Principal investigator: Elizabeth Bouchard, PhD — Roswell Park Comprehensive Cancer Center
- Study coordinator: Elizabeth Bouchard, PhD
- Email: Elizabeth.Bouchard@roswellpark.rog
- Phone: 716-845-1300
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ph+ ALL in Chinese Children: Diagnosis, Treatment, and Survival
This study tests how children in China with Philadelphia chromosome–positive ALL are diagnosed, treated, and how long they survive in real-world practice.
-
Finding the right dose of MB-CART2219.1 CAR‑T (targets CD19 and CD22) for relapsed B‑cell cancers
This trial will test MB‑CART2219.1, a CAR‑T cell therapy that targets CD19 and CD22, in adults and children with relapsed or refractory B‑cell cancers to find a safe dose.
-
Impact of massage therapy on sleep in young cancer patients
This study is testing whether personalized massage therapy can help young cancer patients in the hospital sleep better and feel less tired, anxious, and in pain during their treatment.
-
CAR-T cell therapy for children with relapsed leukemia or lymphoma
This study is testing a new CAR-T cell therapy to see if it can help children with relapsed leukemia or lymphoma feel better and improve their chances of recovery.
-
Using virtual reality to ease lumbar punctures in children with leukemia
This study is testing whether using virtual reality can help kids with leukemia feel less pain and anxiety during lumbar punctures, so they might not need general anesthesia.
-
Comparing two conditioning regimens for pediatric leukemia treatment
This study is testing which of two treatment plans, Total Body Irradiation or Total Marrow, Central Nervous System and Lymphoid Irradiation, works better for kids with leukemia getting a stem cell transplant to help them feel better and live longer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.